يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Creignou, Maria"', وقت الاستعلام: 0.67s تنقيح النتائج
  1. 1
    مؤتمر

    المصدر: Grosicki , S , Dhakal , B , Malek , E , Creignou , M , Jurczak , W , Broijl , A , Iversen , K F , Gregersen , H , Radocha , J , Chen , J , Ogunkanmi , A & Spencer , A 2023 , ' GEN3014 (HexaBody ® -CD38) versus daratumumab in patients with relapsed/ refractory multiple myeloma: design of randomized head-to-head expansion cohort of phase 1/2 trial ' , Clinical Lymphoma, Myeloma & Leukemia , vol. 2 , no. Suppl. 2 , P-050 , pp. S62-S63 . < http://10.1016/S2152-2650Test(23)01668-3 >

  2. 2
    مؤتمر

    المصدر: Spencer , A , Iversen , K F , Dhakal , B , Creignou , M , Chen , J , Hiemstra , I H , Bosgra , S , Badani , A , Breij , E C W , Brady , L K , Sasser , A K , Malmberg , A , Gregersen , H , Hansson , M , Broijl , A , Mateos , M-V & Plesner , T 2022 , ' Preliminary Dose-Escalation Results from a Phase 1/2 Study of GEN3014 (HexaBody (R)-CD38) in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM) ' ....